Literature DB >> 23117823

Core promoter-selective coregulators of transcription by RNA polymerase II.

Ernest Martinez1.   

Abstract

The core promoter of eukaryotic genes is structurally and functionally diverse and contributes to the combinatorial control of gene-specific transcription. Recent findings identifying specific coactivators and architectural proteins as core promoter-specific basal cofactors for RNA polymerase II suggest possible mechanisms for the core promoter selectivity of certain regulators and enhancers.

Keywords:  HMG proteins; Mediator; RNA polymerase II; TFIID; coactivators; core promoter-selective transcription; general transcription factors; positive and negative transcription cofactors

Mesh:

Substances:

Year:  2012        PMID: 23117823      PMCID: PMC3630184          DOI: 10.4161/trns.21846

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  29 in total

Review 1.  HMGA proteins: flexibility finds a nuclear niche?

Authors:  Raymond Reeves
Journal:  Biochem Cell Biol       Date:  2003-06       Impact factor: 3.626

Review 2.  Structure and mechanism of the RNA polymerase II transcription machinery.

Authors:  Steven Hahn
Journal:  Nat Struct Mol Biol       Date:  2004-05       Impact factor: 15.369

3.  Family of proteins that interact with TFIID and regulate promoter activity.

Authors:  M Meisterernst; R G Roeder
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

4.  Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II.

Authors:  C P Verrijzer; J L Chen; K Yokomori; R Tjian
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

5.  Activation of the TFIID-TFIIA complex with HMG-2.

Authors:  B M Shykind; J Kim; P A Sharp
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

6.  A basal transcription factor that activates or represses transcription.

Authors:  P J Willy; R Kobayashi; J T Kadonaga
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

7.  Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription.

Authors:  J A Inostroza; F H Mermelstein; I Ha; W S Lane; D Reinberg
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

8.  Core promoter-specific function of a mutant transcription factor TFIID defective in TATA-box binding.

Authors:  E Martinez; Q Zhou; N D L'Etoile; T Oelgeschläger; A J Berk; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism.

Authors:  D T Auble; K E Hansen; C G Mueller; W S Lane; J Thorner; S Hahn
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

10.  TATA-binding protein-associated factor(s) in TFIID function through the initiator to direct basal transcription from a TATA-less class II promoter.

Authors:  E Martinez; C M Chiang; H Ge; R G Roeder
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

View more
  4 in total

1.  Taspase1 processing alters TFIIA cofactor properties in the regulation of TFIID.

Authors:  Barbora Malecová; Valentina S Caputo; Diane F Lee; James J Hsieh; Thomas Oelgeschläger
Journal:  Transcription       Date:  2015

2.  Characterization of regulatory sequences in alternative promoters of hypermethylated genes associated with tumor resistance to cisplatin.

Authors:  Mohammed A Ibrahim-Alobaide; Abdelsalam G Abdelsalam; Hytham Alobydi; Kakil Ibrahim Rasul; Ruiwen Zhang; Kalkunte S Srivenugopal
Journal:  Mol Clin Oncol       Date:  2014-11-27

3.  Core promoter-specific gene regulation: TATA box selectivity and Initiator-dependent bi-directionality of serum response factor-activated transcription.

Authors:  Muyu Xu; Elsie Gonzalez-Hurtado; Ernest Martinez
Journal:  Biochim Biophys Acta       Date:  2016-01-26

4.  Engineered Promoters for Potent Transient Overexpression.

Authors:  Dan Y Even; Adi Kedmi; Shani Basch-Barzilay; Diana Ideses; Ravid Tikotzki; Hila Shir-Shapira; Orit Shefi; Tamar Juven-Gershon
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.